0001749931-18-000001.txt : 20180813 0001749931-18-000001.hdr.sgml : 20180813 20180810192720 ACCESSION NUMBER: 0001749931-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180813 DATE AS OF CHANGE: 20180810 EFFECTIVENESS DATE: 20180813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC CENTRAL INDEX KEY: 0001749931 IRS NUMBER: 830799659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-319022 FILM NUMBER: 181010052 BUSINESS ADDRESS: STREET 1: 300 S. WACKER DRIVE SUITE 2750 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-276-4529 MAIL ADDRESS: STREET 1: 300 S. WACKER DRIVE SUITE 2750 CITY: CHICAGO STATE: IL ZIP: 60606 D 1 primary_doc.xml X0708 D LIVE 0001749931 Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC 300 S. WACKER DRIVE SUITE 2750 CHICAGO IL ILLINOIS 60606 312-276-4529 DELAWARE None None Limited Liability Company true 2018 J Patrick Barry 300 S. WACKER DRIVE SUITE 2750 CHICAGO IL ILLINOIS 60606 Executive Officer Investing Decline to Disclose 06b false 2018-08-06 false true false 50000 5000000 2200000 2800000 false 11 0 true 0 true 0 true false Neopharm III Series, a separate series of Granite Hall Master Fund Series LLC J. Patrick Barry J. Patrick Barry Chief Investment Officer 2018-08-10